As the first weekly formulation of GLP-1 to be marketed, Bydureon has greatly improved patient compliance
New York Medicaid (NYRx) excludes GLP-1 medications for weight loss under 18 NYCRR 505.3(g)(3)
Semaglutide additionally raises insulin levels to enhance glycemic control, reinforcing satiety and promoting homeostatic eating [8, 9]
Chidester has set out to make these issues a thing of the past by asking patients to pause GLP-1s for six weeks before and six weeks after surgery to bolster nutrition
Oral semaglutide tablets offer an alternative for patients who prefer not to self-inject, at $289/mo month-to-month, or from $249/mo on the 6-month plan
Understanding your genetic context for B vitamin metabolism can support a more informed conversation with your provider about whether to pursue MIC B12 therapy, optimal injection frequency, and whether proper refrigeration and consistent dosing will address your specific metabolic needs